peroxynitrous acid has been researched along with Emphysema in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumgart-Vogt, E; Bednorz, M; Brandes, RP; Buchmann, G; Dorfmüller, P; Eichstaedt, C; Fysikopoulos, A; Gattenlöhner, S; Geiszt, M; Ghofrani, HA; Gredic, M; Grimminger, F; Grünig, E; Günther, A; Hadzic, S; Hecker, A; Hecker, M; Henneke, I; Hinderhofer, K; Jaksch, P; Kanbagli, ZI; Karnati, S; Klepetko, W; Knoepp, F; Kojonazarov, B; Kraut, S; Müller, N; Padberg, W; Pak, O; Parajuli, N; Pichl, A; Rezende, F; Scheibe, S; Schermuly, RT; Schröder, K; Seeger, W; Seimetz, M; Sommer, N; Veith, C; Vogelmeier, CF; Weissmann, N; Wilhelm, J; Wittig, I; Wu, CY | 1 |
1 other study(ies) available for peroxynitrous acid and Emphysema
| Article | Year |
|---|---|
NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Emphysema; Humans; Hypertension, Pulmonary; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Peroxynitrous Acid; Pulmonary Disease, Chronic Obstructive; Signal Transduction; Superoxides; Tobacco Smoke Pollution; Tyrosine | 2020 |